Unknown

Dataset Information

0

Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients.


ABSTRACT: The systemic inflammation response index (SIRI) is a useful tool for predicting prognosis in some types of cancer. In this retrospective study, we evaluated the efficacy of SIRI in predicting overall survival in hepatocellular carcinoma (HCC) patients following local or systemic therapy. A cutoff value of 1.05 was identified for SIRI using ROC analysis in a training patient cohort. In the validation cohort, survival analysis revealed that median overall survival was longer in HCC patients with SIRI scores < 1.05 than in those with scores ? 1.05. Cox analysis of the validation cohort demonstrated that SIRI was associated with overall survival and was more predictive of overall survival that the AFP level or Child-Pugh score. However, SIRI and Barcelona Clinic Liver Cancer (BCLC) stage were equally effective for predicting survival. In addition, HCC patients with BCLC stage C had higher SIRI scores and poorer overall survival. SIRI also correlated with liver function parameters. Thus SIRI may be a convenient, low cost and reliable tumor marker for predicting prognosis in HCC patients.

SUBMITTER: Xu L 

PROVIDER: S-EPMC5471025 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients.

Xu Litao L   Yu Shulin S   Zhuang Liping L   Wang Peng P   Shen Yehua Y   Lin Junhua J   Meng Zhiqiang Z  

Oncotarget 20170501 21


The systemic inflammation response index (SIRI) is a useful tool for predicting prognosis in some types of cancer. In this retrospective study, we evaluated the efficacy of SIRI in predicting overall survival in hepatocellular carcinoma (HCC) patients following local or systemic therapy. A cutoff value of 1.05 was identified for SIRI using ROC analysis in a training patient cohort. In the validation cohort, survival analysis revealed that median overall survival was longer in HCC patients with S  ...[more]

Similar Datasets

| S-EPMC7237698 | biostudies-literature
2010-07-20 | E-GEOD-15366 | biostudies-arrayexpress
2010-07-20 | GSE15366 | GEO